Abbott Laboratories Stock Börse Stuttgart
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.32 EUR | +3.04% |
|
0.00% | -24.69% |
| Market Cap | 161B 140B 129B 120B 228B 15,285B 232B 1,551B 601B 7,497B 603B 590B 25,834B | P/E 2026 * |
22.8x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 172B 151B 138B 129B 244B 16,398B 248B 1,664B 645B 8,043B 647B 633B 27,714B | EV / Sales 2026 * |
3.43x | EV / Sales 2027 * | 3.09x |
| Free-Float |
86.73% | Yield 2026 * |
2.76% | Yield 2027 * | 2.95% |
Last Transcript: Abbott Laboratories
| 1 week | +1.61% | ||
| Current month | +1.81% | ||
| 1 month | +7.36% | ||
| 3 months | -8.44% | ||
| 6 months | -23.33% | ||
| Current year | -23.33% |
| 1 week | 79.08 |  | 83.34 |
| 1 month | 74.04 | | 83.34 |
| 3 years | 69.64 | | 134.1 |
| 5 years | 69.64 | | 134.1 |
| 10 years | 34 | | 134.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.04% | 0.00% | -29.76% | -18.05% | 161B | |
| +4.10% | +2.00% | -6.97% | -5.75% | 101B | |
| +1.38% | +1.71% | +0.23% | +52.87% | 56.12B | |
| -1.22% | -2.88% | +53.69% | +49.87% | 53.35B | |
| +2.75% | +3.64% | -11.50% | -40.10% | 42.13B | |
| +2.28% | +12.95% | - | - | 35.29B | |
| +3.47% | +3.61% | -14.90% | -44.00% | 26.57B | |
| +0.04% | +5.61% | +65.44% | -3.26% | 25.79B | |
| +2.06% | +2.61% | -9.30% | -1.39% | 20.69B | |
| +2.69% | +1.40% | -14.89% | -2.92% | 19.59B | |
| Average | +1.95% | +2.76% | +3.56% | -1.41% | 42.32B | |
| Weighted average by Cap. | +2.14% | +1.89% | -4.51% | -1.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.26B 43.91B 40.33B 37.61B 71.29B 4,784B 72.5B 486B 188B 2,347B 189B 185B 8,086B | 54.75B 47.84B 43.93B 40.97B 77.67B 5,212B 78.98B 529B 205B 2,557B 206B 201B 8,809B |
| Net income | 7.02B 6.13B 5.63B 5.25B 9.96B 668B 10.12B 67.8B 26.28B 328B 26.35B 25.78B 1,129B | 8.39B 7.33B 6.73B 6.28B 11.9B 799B 12.1B 81.05B 31.41B 392B 31.5B 30.82B 1,350B |
| Net Debt | 11.69B 10.21B 9.38B 8.75B 16.58B 1,113B 16.86B 113B 43.76B 546B 43.89B 42.94B 1,881B | 8.86B 7.74B 7.11B 6.63B 12.56B 843B 12.78B 85.57B 33.16B 414B 33.26B 32.53B 1,425B |
| Date | Price | Change |
|---|---|---|
| 03/07/26 | EUR 83.06 | +2.72% |
| 01/07/26 | EUR 80.86 | +1.81% |
| 30/06/26 | EUR 79.42 | -2.12% |
| 29/06/26 | EUR 81.14 | -1.60% |
| 26/06/26 | EUR 82.46 | +0.78% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
